Core Viewpoint - *ST Changyao is embroiled in a financial fraud scandal, facing a formal investigation by the China Securities Regulatory Commission (CSRC) due to suspected false reporting of financial data, which could lead to mandatory delisting if deemed a major violation [1][2]. Group 1: Financial Fraud Investigation - The investigation focuses on the authenticity of *ST Changyao's financial data, highlighting severe deficiencies in its information disclosure quality and internal control systems [2]. - The company has already been warned of delisting risks due to a negative net asset value reported for the fiscal year 2024 [2]. Group 2: Deteriorating Operations - Since entering the pharmaceutical industry in 2020 and fully transforming in 2022, *ST Changyao has not achieved expected growth, with revenue plummeting from 1.615 billion yuan in 2022 to 112 million yuan in 2024 [3]. - The company's net profit has been negative for consecutive years, with net assets reported at -433 million yuan by the end of 2024, worsening to -643 million yuan by the end of Q3 2025 [3]. - Operating cash flow has been negative for three consecutive years, raising significant doubts about the company's ability to continue as a going concern [3]. Group 3: Legal and Financial Risks - *ST Changyao is facing multiple legal challenges, with 140 lawsuits involving a total amount of 1.878 billion yuan, which is 434% of its net assets, indicating governance issues and compliance failures [4]. - The company has 1.106 billion yuan in interest-bearing liabilities, with 390 million yuan overdue, leading to severe liquidity issues [4]. - A significant portion of the company's bank accounts, 67.7%, are frozen, impacting daily operations and cash flow management [4]. Group 4: Conclusion - *ST Changyao is undergoing its most severe test since its listing, facing a crisis that requires urgent resolution of debts and regulatory concerns to maintain its position in the capital market [5].

瑞幸2020年在纳斯达克停牌 2017年10月，瑞幸全国首家门店在北京开业，总部则设在福建厦门，瑞幸原创始人陆正耀是神州租车的创始人，他将互联网烧钱的打法搬到了咖啡赛道， 通过不断烧钱补贴用户，拉低了现磨咖啡的购入门槛，同时其不断开店，刷新了咖啡赛道的开店纪录，而在营销方式，其在宣传上多次声称对标星巴克， 还签约了张震、汤唯等多个明星作为代言人。 仅仅创立18个月时间，瑞幸就在美股上市，但在美股上市之后不到一年，2020年2月，瑞幸就被曝出财务造假的丑闻，随后，瑞幸承认确实存在虚假交易 22.46亿元，舆论哗然。在丑闻爆发后，2020年5月，时任瑞幸CEO的钱治亚被停职，次月，瑞幸在纳斯达克正式停牌，同年7月，陆正耀被罢免了董事长 的职务，之后郭谨一接任CEO和董事长。 11月初，根据厦门市工商联发布的视频，在2025年厦门企业家日大会上，瑞幸咖啡CEO郭谨一表示，瑞幸在厦门市委市政府的指导下，正积极推动重回美 国主板上市进程。同时，郭谨一透露，瑞幸预计2025年营业收入超500亿元。 图源：厦门市工商联 对此，11月12日，瑞幸相关负责人告诉南都湾财社记者，瑞幸咖啡会持续关注美国资本市场，但公司目前对于重返 ...

11月12日晚间，*ST广道发布公告，公司收到北交所出具的决定书，根据《股票上市规则》及北交所审议意见，决定终止*ST广道的股票上市，这也是北 交所首家因重大违法而被强制退市的上市公司。 图：*ST广道公告 决定书显示，*ST广道被北交所终止上市，与其长时间、系统性财务造假有关，事实上，*ST广道披露的2018年至2023年年报、2024年半年报均存在虚假 记载。 具体来看，*ST广道通过制作虚假购销合同、发票、银行回单、发货通知单及入库单等方式，虚构销售和采购业务，从而虚增营业收入及营业成本。 图：*ST广道官网 广道数字（现*ST广道）被强制退市，实属意料之中。早在去年12月3日，广道数字就收到了证监会下发的问询函，12月5日，广道数字收到立案告知书： 因公司涉嫌信息披露违法违规，中国证监会决定对公司立案。 随后，公司接连发布《立案调查进展暨风险提示公告》、《银行账户被冻结公告》、《可能被实施退市风险警示公告》。 今年4月29日，公司发布《被实施退市风险警示的公告》，公司股票名称由广道数字变更为*ST广道。 2018年至2023年、2024年上半年，*ST广道虚增的营业收入占当期报告记载金额的比例，分别为 ...

每经编辑｜许绍航 11月12日晚间，*ST广道发布公告，公司收到北交所出具的决定书，根据《股票上市规则》及北交所审议意见，决定终止*ST广道的股票上市，这也是北 交所首家因重大违法而被强制退市的上市公司。 决定书显示，*ST广道被北交所终止上市，与其长时间、系统性财务造假有关，事实上，*ST广道披露的2018年至2023年年报、2024年半年报均存在虚假 记载。 图：*ST广道公告 具体来看，*ST广道通过制作虚假购销合同、发票、银行回单、发货通知单及入库单等方式，虚构销售和采购业务，从而虚增营业收入及营业成本。 2018年至2023年、2024年上半年，*ST广道虚增的营业收入占当期报告记载金额的比例，分别为87.34%、95.39%、98.96%、85.87%、99.39%、98.14%和 88.11%。 2018年至2023年、2024年上半年，*ST广道虚增的营业成本占当期报告记载金额的比例，分别为84.53%、91.17%、98.41%、83.30%、99.13%、92.26%和 83.81%。 资料显示，*ST广道全称"深圳市广道数字技术股份有限公司"，主要从事以数据应用为目标的软件产品的开发与销 ...

本报（chinatimes.net.cn）记者帅可聪 北京报道 重大合同履约出问题不及时披露，一年半时间虚增利润上亿元，浙江东尼电子股份有限公司（下称"东 尼电子"，603595.SH）财务造假案处罚落地。 11月12日晚，东尼电子发布公告称，当天收到浙江证监局下发的行政处罚决定书，公司及6名责任人被 合计1570万元，其中公司被罚700万元。东尼电子称，将积极落实整改，并向广大投资者致以诚挚的歉 意。 其二，东尼电子2022年年度报告、2023年半年度报告存在虚假记载，利润总额分别虚增3877.59万元、 7227.79万元，分别占当期披露金额绝对值的38.63%、70.95%，合计逾1.1亿元。 具体来看，东尼电子的造假手段主要包括：将应确认为研发费用的不良晶体确认为存货，少确认研发费 用；未将关联方代垫资金采购的原材料入账，少确认研发费用和营业成本；未充分计提存货跌价准备， 少确认资产减值损失跌价准备。 其中，2022年至2023年期间，东尼半导体在履行与广东天域签订的相关合同过程中，将应确认为研发费 用的碳化硅衬底项目不良晶体确认为存货，累计少确认研发费用5681.49万元，虚增利润总额5681.49 ...

Core Points - ST Dongni received an administrative penalty of 15.7 million yuan due to delayed disclosure of significant contract progress and false records in its 2022 annual report and 2023 semi-annual report [2][8] - The case reflects the regulatory principle of "early detection, quick punishment, and strict correction," which aims to protect investor rights and save the company [2] - Following the penalty, ST Dongni will enter a one-year observation period and aims to apply for the removal of risk warnings once conditions are met [2] Summary of Major Contract Disclosure - ST Dongni's subsidiary, Dongni Semiconductor, signed a procurement contract worth 675 million yuan with Guangdong Tianyu on January 9, 2023, which accounted for 51.84% of the company's latest audited main business income [4] - The company failed to meet the monthly delivery targets outlined in the contract, achieving only 6.74% of the required deliveries by the end of October 2023, and did not disclose the inability to meet the contract terms until January 6, 2024 [4] Summary of False Records in Reports - The administrative penalty decision revealed that ST Dongni's 2022 annual report and 2023 semi-annual report contained false records, including misclassifying R&D expenses and failing to account for related party transactions, which inflated profits by 38.63% and 70.95% respectively [6][7] - The company will make retrospective adjustments in April 2024 to correct these accounting errors [6] Penalty Details - The Zhejiang Securities Regulatory Bureau imposed a total fine of 15.7 million yuan, with specific penalties for key personnel including the chairman and general manager, who failed to ensure timely and accurate disclosures [9][10] - The company acknowledged the need to strengthen internal control processes and compliance following the penalty [10]

Core Viewpoint - Dongni Electronics faces significant risks due to high share pledges by its actual controllers and financial fraud that has triggered ST warning, leading to a sharp decline in stock price [1][4]. Financial Fraud and Regulatory Actions - Dongni Electronics has been penalized for financial fraud, receiving a warning and a fine of 7 million yuan, with six responsible individuals fined a total of 8.7 million yuan [1][2]. - The company’s stock will be subject to risk warnings starting October 31, 2025, due to the severity of the financial fraud, which included significant contract disclosure delays and inflated profits [1][4]. Stock Performance and Management Actions - Following the financial fraud revelations, Dongni Electronics' stock has experienced four consecutive trading halts, with a total decline of nearly 20% since October 30 [1][4]. - During the period of financial misconduct, the company's stock price surged from around 22 yuan per share in April 2022 to over 80 yuan per share in January 2023, marking an increase of nearly three times [4]. Debt and Financial Health - As of the end of the third quarter, Dongni Electronics has short-term debts exceeding 1.3 billion yuan, while its cash reserves are only 42 million yuan, raising concerns about potential debt default [5]. - The company reported a net loss of 14.6 million yuan in the third quarter, despite a slight increase in total revenue to 1.457 billion yuan, indicating ongoing financial struggles [5]. Business Segment Performance - The consumer electronics segment, which is a core part of Dongni Electronics' business, has shown weak performance, while the new energy segment has seen significant revenue and profit growth [6]. - The solar business has contracted, with both revenue and profit declining due to falling prices in the solar industry, prompting the company to reduce its traditional solar business scale [6].

Core Viewpoint - Dongni Electronics faces potential bankruptcy risk due to high share pledges and significant short-term debt exceeding 1.3 billion yuan, while cash on hand is less than 0.1 billion yuan [1][10]. Financial Misconduct - Dongni Electronics triggered the ST warning line due to financial misconduct, resulting in a stock price crash and a 700 million yuan fine from regulators [1][3]. - The company failed to disclose significant contract progress and inflated profits through various accounting manipulations, leading to a profit inflation of 38.63% and 70.95% for 2022 and 2023, respectively [5][6]. Stock Performance - The stock price surged nearly threefold from around 22 yuan per share in April 2022 to over 80 yuan in January 2023, during which executives sold shares [6][8]. - Following the financial misconduct announcement, the stock experienced four consecutive trading halts, with a total decline of nearly 20% by November 12 [1][6]. Shareholder Pledge Situation - The actual controllers of Dongni Electronics, Shen Xinfang and Shen Xiaoyu, have pledged approximately 79.35% of their shares, raising concerns about potential liquidation risks as the stock price has dropped significantly since the pledge [10][12]. Debt and Financial Health - As of the third quarter, the company reported short-term debts exceeding 1.3 billion yuan, while cash reserves were only 0.42 billion yuan, indicating potential liquidity issues [10][13]. - The company reported a total revenue of 1.457 billion yuan for the third quarter, a year-on-year increase of 1.5%, but still posted a net loss of 14.61 million yuan [13]. Business Segment Performance - The consumer electronics segment, while still a core business, showed weak performance despite a slight revenue increase, with a gross margin of 24.36% [14]. - The renewable energy segment performed well, with significant revenue and gross margin growth, while the photovoltaic segment faced declines due to market conditions [15].

来源：市场资讯 （来源：IPO热点） 一、公司背景与高光时刻 诺辉健康成立于2015年，由朱叶青、姚纳新、陈一友三位北大校友联合创立，定位为"中国癌症早筛领 导者"。其核心产品常卫清于2020年11月获得国家药监局（NMPA）批准，成为中国首个获批的结直肠 癌早筛三类医疗器械，被誉为"居家癌症筛查里程碑"。 凭借这一"首证"光环，诺辉健康在2021年2月登陆港交所，发行价26.66港元，募资超20亿港元。上市后 股价一度飙升至89.65港元，市值突破400亿港元，成为港股"医疗科技明星股"。 然而，这场资本盛宴背后，早已埋下崩塌的种子。 二、核心团队：创始人主导，封闭决策 1. 创始人角色明确 朱叶青：CEO兼董事会主席，被多方证据证实为造假总策划者。其主导制定"业绩优先"战略，要求销售 团队"不惜代价完成KPI"。 姚纳新、陈一友：虽未直接参与造假执行，但在关键决策中保持沉默。2025年另起炉灶成立"杭州程控 数芯生物科技"，试图切割历史包袱。 2. 组织文化高度封闭 每周销售会议设为"最高机密"，非销售线员工禁止参与。 内部流传"忠诚高于能力"的用人标准，一线销售被灌输"公司利益至上"理念。 财务、法务部 ...

35个连续跌停，直到退市最后一刻都没有再给机会。 ST高鸿用这种极端方式，给A股市场的8.38万名股东上了一堂血淋淋的风险教育课。 最让人难以置信的是，在第24个跌停板后，股价已经跌至0.66元时，竟 然还有2.1万名投资者冲进去博反弹，结果全部被埋。 2025年11月11日，ST高鸿正式终止上市摘牌。 这只曾经辉煌的通信设备行业股票，最终以0.38元的股价告别A股市场。 从历史高点19.80元算起，股价跌幅 超过98%，意味着最早持有的投资者几乎血本无归。 这两天的开板成为了人性的试金石。 部分深套的投资者选择坚守，期待主力资金会拉升自救。 更有2.1万名新投资者认为已经跌到位，大举进场博取反弹收 益。 然而市场给了他们最残酷的回应——开板两天后，ST高鸿再次开启一字跌停模式，直到退市都没有再给逃命机会。 从股东结构变化可以看出投资者的非理性行为。 尽管公司问题已经暴露，但股东总数在退市时仍达到8.38万人。 这背后反映的是部分投资者对国企身份的 过度信赖，总认为"国企不会轻易退市"，结果付出了惨重代价。 亏损数据的分布更能说明问题。 持股时间最长的投资者亏损幅度达到98.10%，近两年进场的亏损95%，就 ...